Showing Results for: “diabetes”

This week, Senate Bill 1677, a lifesaving piece of legislation championed by the American Diabetes Association ® (ADA) that establishes a comprehensive study on the prevention and reduction of diabetes-related amputations, became law in Texas. Texas has one of the highest rates in the nation for people undergoing diabetes-related amputations, at about 52 per 100,000 hospital admissions. This proactive and fiscally responsible measure will help improve health outcomes and reduce costs related to amputation. "The passage of Senate Bill 1677 demonstrates a commitment to the health of our citizens

Today, from the main stage at the organization’s 2026 Scientific Sessions, the American Diabetes Association ® (ADA) announced the winners of the 2026 Innovation Challenge competition. Each year, the Innovation Challenge seeks game-changing ideas from emerging companies that have the potential to transform diabetes care. “There is tremendous excitement around advances in diabetes care right now. We’re proud to support continued innovation and investment in possibilities that bring us ever closer to the ADA’s vision of a life free of diabetes and all its burdens. Congratulations to this year’s

The Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) trial has found dulaglutide, an injectable, glucagon-like peptide-1 (GLP-1) receptor agonist, demonstrates superiority in the reduction of cardiovascular events for a broad range of people living with type 2 diabetes (T2D), according to research presented today at a symposium at the American Diabetes Association’s® (ADA’s) 79th Scientific Sessions®. The REWIND trial is the first study to include a majority of participants (69%) with no history of cardiovascular disease (CVD) at enrollment. Additionally, the

For many years, the American Diabetes Association® (ADA) has worked closely with members of Congress and their staff to advance policies that help individuals, families, and communities prevent and manage diabetes. As the important work of the 119 th Congress gets underway, the ADA shared the following legislative priorities in a letter to members. Insulin Affordability Ensuring insulin is affordable and accessible for those who need it to live is a top priority for ADA. One in four Americans with diabetes reports rationing insulin to pay for other life essentials like rent, utilities

Today, the American Diabetes Association ® (ADA) sent a letter to congressional leadership urging action on legislation to increase transparency in prescription drug rebates and prevent pharmacy benefit manager (PBM) practices from inflating the cost of prescription drugs. “Drug middlemen function at the center of the pharmaceutical supply chain and have virtually unparalleled power to affect drug costs, acting as intermediaries between insurers, manufacturers, and pharmacies,” according to the letter. Drug manufacturers often pay PBMs rebates on their drugs in exchange for coverage, limiting

Today, the American Diabetes Association® (ADA) released a guidance statement on the use of compounded GLP-1 RA (glucagon-like peptide-1 receptor agonist) and dual GIP/GLP-1 RA (glucose-dependent insulinotropic polypeptide and GLP-1 RA) medication classes. The statement recommends against using non-Food & Drug Administration (FDA)-approved compounded GLP-1 and dual GIP/GLP-1 RA products due to uncertainty about their content, safety, quality, and effectiveness. GLP-1 RA and dual GIP and GLP-1 RA medication classes are recommended by the ADA’s Standards of Care in Diabetes for use in people

Join Drs. Neil Skolnik and Sara Wettergreen as they discuss key takeaways from the ADA's 85th Scientific Sessions in Chicago, highlighting advancements in diabetes and obesity care. With guests, Drs. Osagie Ebekozien and Marlon Pragnell, they'll explore how these advancements can positively impact you and your loved ones.

Community program seeks to understand how to increase access to health technology for underserved diabetes communities Abbott and the American Diabetes Association ® (ADA) announced today the launch of their first joint community health partnership. The community initiative, which is the first program under the ADA's Health Equity Now™ platform 1, will launch in Columbus, Ohio, and be conducted in partnership with the National Center for Urban Solutions (NCUS), a Columbus-based organization focused on providing solutions in workforce development, education and wellness. The program seeks to

When I was 10 years old, I was misdiagnosed with type 2 diabetes. I stayed home from school that day because I was not feeling well. I ended up going to the hospital because I was gasping for air. My blood sugar was 1,149, which is dangerously high. I am thankful everyday that I am alive because that was very scary. I had to quickly acclimate to a new life where I was learning to give myself insulin shots and count carbohydrates. I ended up finding a diabetes camp, ADA Camp Midicha, a few years later and it was truly incredible. I got to be around people who knew what I was going through. I

As part of our commitment to reduce the incidence of diabetes, we are working with the Centers for Disease Control and Prevention (CDC)’s National Diabetes Prevention Program (National DPP) to implement a key feature of the program—a research-based, structured lifestyle change program that is proven to help prevent and delay the development of type 2 diabetes. Before people develop type 2 diabetes, they almost always have prediabetes—where blood glucose (also called blood sugar) levels are higher than normal but not yet high enough to be diabetes. Prediabetes is very common. Approximately 88